NO802256L - Fremgangsmaate for fremstilling av nye halogenderivater av 16alfa-methylpregnanrekken - Google Patents
Fremgangsmaate for fremstilling av nye halogenderivater av 16alfa-methylpregnanrekkenInfo
- Publication number
- NO802256L NO802256L NO802256A NO802256A NO802256L NO 802256 L NO802256 L NO 802256L NO 802256 A NO802256 A NO 802256A NO 802256 A NO802256 A NO 802256A NO 802256 L NO802256 L NO 802256L
- Authority
- NO
- Norway
- Prior art keywords
- 16alfa
- methyl
- procedure
- preparation
- halogen derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7919296A FR2462443A1 (fr) | 1979-07-26 | 1979-07-26 | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO802256L true NO802256L (no) | 1981-01-27 |
| NO153102B NO153102B (no) | 1985-10-07 |
| NO153102C NO153102C (no) | 1986-01-15 |
Family
ID=9228325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO802256A NO153102C (no) | 1979-07-26 | 1980-07-25 | Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4353899A (no) |
| JP (1) | JPS5622798A (no) |
| AT (1) | AT371483B (no) |
| AU (1) | AU528292B2 (no) |
| BE (1) | BE884494A (no) |
| CA (1) | CA1141751A (no) |
| CH (1) | CH645389A5 (no) |
| DE (1) | DE3028255C2 (no) |
| DK (1) | DK146690C (no) |
| FI (1) | FI66880C (no) |
| FR (1) | FR2462443A1 (no) |
| GB (1) | GB2054600B (no) |
| HU (1) | HU180364B (no) |
| IE (1) | IE50031B1 (no) |
| IT (1) | IT1145302B (no) |
| MX (1) | MX6649E (no) |
| NL (1) | NL8004282A (no) |
| NO (1) | NO153102C (no) |
| SE (1) | SE447387B (no) |
| ZA (1) | ZA803867B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2533928A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
| FR2561919B1 (fr) * | 1984-04-03 | 1986-12-19 | Roussel Uclaf | Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon |
| DE19932511A1 (de) * | 1999-07-12 | 2001-01-18 | Helmig Hans Gmbh | Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL122815C (no) * | 1963-12-19 | |||
| FR2342738A1 (fr) * | 1976-03-02 | 1977-09-30 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
| FR2381065A2 (fr) * | 1977-02-22 | 1978-09-15 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16 a-methyl pregnane |
-
1979
- 1979-07-26 FR FR7919296A patent/FR2462443A1/fr active Granted
-
1980
- 1980-06-13 SE SE8004428A patent/SE447387B/sv not_active IP Right Cessation
- 1980-06-19 HU HU80801526A patent/HU180364B/hu not_active IP Right Cessation
- 1980-06-26 ZA ZA00803867A patent/ZA803867B/xx unknown
- 1980-07-01 FI FI802092A patent/FI66880C/fi not_active IP Right Cessation
- 1980-07-15 IT IT49248/80A patent/IT1145302B/it active
- 1980-07-15 MX MX808920U patent/MX6649E/es unknown
- 1980-07-22 CA CA000356705A patent/CA1141751A/fr not_active Expired
- 1980-07-25 DE DE3028255A patent/DE3028255C2/de not_active Expired
- 1980-07-25 DK DK321180A patent/DK146690C/da active
- 1980-07-25 CH CH573280A patent/CH645389A5/fr not_active IP Right Cessation
- 1980-07-25 JP JP10142880A patent/JPS5622798A/ja active Granted
- 1980-07-25 IE IE1561/80A patent/IE50031B1/en unknown
- 1980-07-25 AU AU60811/80A patent/AU528292B2/en not_active Ceased
- 1980-07-25 NL NL8004282A patent/NL8004282A/nl not_active Application Discontinuation
- 1980-07-25 NO NO802256A patent/NO153102C/no unknown
- 1980-07-25 BE BE0/201544A patent/BE884494A/fr not_active IP Right Cessation
- 1980-07-28 AT AT0391380A patent/AT371483B/de not_active IP Right Cessation
- 1980-07-28 GB GB8024660A patent/GB2054600B/en not_active Expired
-
1981
- 1981-09-08 US US06/300,252 patent/US4353899A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BE884494A (fr) | 1981-01-26 |
| CH645389A5 (fr) | 1984-09-28 |
| US4353899A (en) | 1982-10-12 |
| DE3028255C2 (de) | 1985-12-19 |
| FR2462443A1 (fr) | 1981-02-13 |
| FR2462443B1 (no) | 1982-12-31 |
| JPS6254438B2 (no) | 1987-11-14 |
| GB2054600A (en) | 1981-02-18 |
| FI66880C (fi) | 1984-12-10 |
| HU180364B (en) | 1983-02-28 |
| FI802092A (fi) | 1981-01-27 |
| DK146690B (da) | 1983-12-05 |
| MX6649E (es) | 1985-10-01 |
| DE3028255A1 (de) | 1981-02-19 |
| AU6081180A (en) | 1981-01-29 |
| GB2054600B (en) | 1983-02-02 |
| IE50031B1 (en) | 1986-02-05 |
| AU528292B2 (en) | 1983-04-21 |
| ZA803867B (en) | 1981-06-24 |
| IT1145302B (it) | 1986-11-05 |
| JPS5622798A (en) | 1981-03-03 |
| NO153102B (no) | 1985-10-07 |
| CA1141751A (fr) | 1983-02-22 |
| FI66880B (fi) | 1984-08-31 |
| IT8049248A0 (it) | 1980-07-15 |
| ATA391380A (de) | 1982-11-15 |
| SE8004428L (sv) | 1981-01-27 |
| AT371483B (de) | 1983-06-27 |
| NO153102C (no) | 1986-01-15 |
| NL8004282A (nl) | 1981-01-28 |
| IE801561L (en) | 1981-01-26 |
| DK321180A (da) | 1981-01-27 |
| DK146690C (da) | 1984-05-21 |
| SE447387B (sv) | 1986-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO803868L (no) | Fremgangsmaate ved fremstilling av nye kinazolinderivater | |
| NO801014L (no) | Fremgangsmaate for fremstilling av nye piperidinderivater | |
| NO800650L (no) | Fremgangsmaate ved fremstilling av nye indolderivater | |
| NO792760L (no) | Fremgangsmaate ved fremstilling av nye nafthydrinderivater | |
| NO792823L (no) | Fremgangsmaate ved fremstilling av nye arginiamidderivater | |
| NO770841L (no) | Fremgangsm}te for fremstilling av nye imidazo-tiazol-derivater | |
| NO151895C (no) | Fremgangsmaate for fremstilling av pyrido-indolderivater | |
| NO821847L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
| SE7803035L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| ES493107A0 (es) | Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol | |
| NO784382L (no) | Fremgangsmaate for fremstilling av tiazoldin-derivater | |
| NO770940L (no) | Fremgangsm}te for fremstilling av karbostyrilderivater | |
| NO802402L (no) | R fremgangsmaate ved fremstilling av nye halovincamonderivate | |
| DK136180A (da) | Fremgangsmaade til fremstilling af nye anthralinderivater | |
| SE7707407L (sv) | Forfarande for framstellning av cefamderivat | |
| NO802435L (no) | Fremgangsmaate til fremstilling av tetrahydrokinolinderivater | |
| NO802256L (no) | Fremgangsmaate for fremstilling av nye halogenderivater av 16alfa-methylpregnanrekken | |
| NO780389L (no) | Fremgangsmaate for fremstilling av erytromycin-derivater | |
| SE419083B (sv) | Analogiforfarande for framstellning av nikotinoylamino-triazinderivat | |
| NO792659L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater | |
| NO801236L (no) | Fremgangsmaate for fremstilling av halogenderivater av isopropylaminopyrimidin | |
| NO801234L (no) | Fremgangsmaate for fremstilling av isopropylaminopyrimidin-hydroksyderivater | |
| NO801724L (no) | Fremgangsmaate for fremstilling av ergopeptin-derivater | |
| NO800564L (no) | Fremgangsmaate for fremstilling av penicillinderivater | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat |